| Insight into Sweet's syndrome and associated-malignancy: a review of the current literature S Raza, RS Kirkland, AA Patel, JR Shortridge, C Freter International journal of oncology 42 (5), 1516-1522, 2013 | 129 | 2013 |
| Structural racism is a mediator of disparities in acute myeloid leukemia outcomes IE Abraham, GH Rauscher, AA Patel, WB Pearse, P Rajakumar, M Burkart, ... Blood, The Journal of the American Society of Hematology 139 (14), 2212-2226, 2022 | 45 | 2022 |
| Sequence requirements for combinatorial recognition of histone H3 by the MRG15 and Pf1 subunits of the Rpd3S/Sin3S corepressor complex GS Kumar, W Chang, T Xie, A Patel, Y Zhang, GG Wang, G David, ... Journal of molecular biology 422 (4), 519-531, 2012 | 32 | 2012 |
| Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib AA Patel, K Cahill, A Charnot-Katsikas, H Liu, S Gurbuxani, M Thirman, ... British journal of haematology 190 (1), e48-e51, 2020 | 29 | 2020 |
| Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab T Badar, A Szabo, A Advani, M Wadleigh, S Arslan, MA Khan, I Aldoss, ... Blood advances 4 (10), 2308-2316, 2020 | 29 | 2020 |
| Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults AA Patel, J Thomas, AE Rojek, W Stock Current Treatment Options in Oncology 21, 1-21, 2020 | 28 | 2020 |
| Outcomes of TP53 Mutated AML with Evolving Frontline Therapies: Impact of Allogeneic Stem Cell Transplantation on Survival T Badar, E Atallah, RM Shallis, AD Goldberg, A Patel, Y Abaza, ... American Journal of Hematology, 2022 | 27 | 2022 |
| The next generation of JAK inhibitors: An update on fedratinib, momelotonib, and pacritinib AA Patel, O Odenike Current Hematologic Malignancy Reports 15, 409-418, 2020 | 26 | 2020 |
| Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies AA Patel, K Cahill, C Saygin, O Odenike Blood Advances 5 (8), 2264-2271, 2021 | 23 | 2021 |
| FOXM1 contributes to treatment failure in acute myeloid leukemia I Khan, M Halasi, A Patel, R Schultz, N Kalakota, YH Chen, N Aardsma, ... JCI insight 3 (15), 2018 | 23 | 2018 |
| Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second … T Badar, A Szabo, S Dinner, M Liedtke, M Burkart, RM Shallis, ... Cancer 127 (7), 1039-1048, 2021 | 18 | 2021 |
| Therapy-Related Myeloid Neoplasms in 109 Patients Following Radiation Monotherapy AA Patel, AE Rojek, MW Drazer, H Weiner, LA Godley, MM Le Beau, ... Blood Advances 5 (20), 4140-4148, 2021 | 17 | 2021 |
| Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement T Carll, A Patel, B Derman, E Hyjek, A Lager, P Wanjari, J Segal, ... Blood Advances 4 (19), 4924-4928, 2020 | 16 | 2020 |
| Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on … T Badar, E Atallah, R Shallis, AN Saliba, A Patel, JP Bewersdorf, J Grenet, ... Leukemia 37 (4), 799-806, 2023 | 15 | 2023 |
| Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity H Fan, S Xia, J Xiang, Y Li, MO Ross, SA Lim, F Yang, J Tu, L Xie, ... Nature 623 (7989), 1034-1043, 2023 | 14 | 2023 |
| Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic … T Badar, A Szabo, M Litzow, M Burkart, I Yurkiewicz, S Dinner, M Hefazi, ... Bone Marrow Transplantation 56 (8), 1998-2004, 2021 | 12 | 2021 |
| Genomics of MPN progression AA Patel, O Odenike Hematology 2014, the American Society of Hematology Education Program Book …, 2020 | 12 | 2020 |
| Peabody's paradox: balancing patient care and medical education in a pandemic SW Russell, N Ahuja, A Patel, P O'Rourke, SV Desai, BT Garibaldi Journal of graduate medical education 12 (3), 264-268, 2020 | 10 | 2020 |
| Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults AA Patel, J Heng, E Dworkin, S Monick, BA Derman, AS DuVall, ... eJHaem 2 (3), 413-420, 2021 | 9 | 2021 |
| Impact of race on outcomes in intermediate-risk acute myeloid leukemia IE Abraham, AA Patel, H Wang, JP Galvin, O Frankfurt, L Liu, I Khan Cancer Causes & Control, 1-8, 2021 | 9 | 2021 |
Talha BadarDivision of Hematology and Oncology, Mayo Clinic, Florida, USAVerified email at mayo.edu
